卡塔尔的无声流行病:关于代谢综合征患病率的综合元分析。

IF 2.4 Q3 ENDOCRINOLOGY & METABOLISM
Sarah Aqel, Jamil Ahmad, Sebawe Syaj, Majd N Daoud, Bashar Araiqat
{"title":"卡塔尔的无声流行病:关于代谢综合征患病率的综合元分析。","authors":"Sarah Aqel, Jamil Ahmad, Sebawe Syaj, Majd N Daoud, Bashar Araiqat","doi":"10.2174/0115733998286706240129074153","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Metabolic syndrome comprises various conditions like abdominal obesity, insulin resistance, elevated triglyceride levels, reduced HDL, and high blood pressure, which pose significant health challenges globally. It's imperative to determine its prevalence in specific populations to formulate effective preventive measures.</p><p><strong>Objective: </strong>This systematic review and meta-analysis aimed to determine the prevalence of metabolic syndrome in the Qatari population.</p><p><strong>Methods: </strong>Using the PRISMA guidelines, a systematic search was executed on PubMed until July 2023 with keywords \"Metabolic syndrome\" and \"Qatar.\" Eligibility criteria included human subjects, studies assessing metabolic syndrome components, and research conducted in Qatar or on Qatari subjects. The quality of the studies was evaluated using the Newcastle-Ottawa Scale (NOS). Pooled prevalence rates were calculated using the inverse variance weighting metaanalysis.</p><p><strong>Results: </strong>Out of 237 studies, 14 met our inclusion criteria, with a combined sample size of 14,772 from the Qatari population. The overall pooled prevalence of metabolic syndrome was 26%. The ATP III and IDF criteria exhibited significant differences in prevalence rates, with the IDF criteria showing a higher prevalence. Age ≥ 40 years demonstrated a higher prevalence compared to the younger group. Studies post-2018 reported a decreasing trend in metabolic syndrome prevalence.</p><p><strong>Conclusion: </strong>The prevalence of metabolic syndrome in the Qatari population is comparable to rates in the Middle East. The study underscores the need for tailored interventions and strategies, especially targeting the older age group. Continuous research and monitoring are essential to track and understand the disease's progression in Qatar.</p>","PeriodicalId":10825,"journal":{"name":"Current diabetes reviews","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Qatar's Silent Epidemic: A Comprehensive Meta-analysis on the Prevalence of Metabolic Syndrome.\",\"authors\":\"Sarah Aqel, Jamil Ahmad, Sebawe Syaj, Majd N Daoud, Bashar Araiqat\",\"doi\":\"10.2174/0115733998286706240129074153\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Metabolic syndrome comprises various conditions like abdominal obesity, insulin resistance, elevated triglyceride levels, reduced HDL, and high blood pressure, which pose significant health challenges globally. It's imperative to determine its prevalence in specific populations to formulate effective preventive measures.</p><p><strong>Objective: </strong>This systematic review and meta-analysis aimed to determine the prevalence of metabolic syndrome in the Qatari population.</p><p><strong>Methods: </strong>Using the PRISMA guidelines, a systematic search was executed on PubMed until July 2023 with keywords \\\"Metabolic syndrome\\\" and \\\"Qatar.\\\" Eligibility criteria included human subjects, studies assessing metabolic syndrome components, and research conducted in Qatar or on Qatari subjects. The quality of the studies was evaluated using the Newcastle-Ottawa Scale (NOS). Pooled prevalence rates were calculated using the inverse variance weighting metaanalysis.</p><p><strong>Results: </strong>Out of 237 studies, 14 met our inclusion criteria, with a combined sample size of 14,772 from the Qatari population. The overall pooled prevalence of metabolic syndrome was 26%. The ATP III and IDF criteria exhibited significant differences in prevalence rates, with the IDF criteria showing a higher prevalence. Age ≥ 40 years demonstrated a higher prevalence compared to the younger group. Studies post-2018 reported a decreasing trend in metabolic syndrome prevalence.</p><p><strong>Conclusion: </strong>The prevalence of metabolic syndrome in the Qatari population is comparable to rates in the Middle East. The study underscores the need for tailored interventions and strategies, especially targeting the older age group. Continuous research and monitoring are essential to track and understand the disease's progression in Qatar.</p>\",\"PeriodicalId\":10825,\"journal\":{\"name\":\"Current diabetes reviews\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current diabetes reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0115733998286706240129074153\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current diabetes reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115733998286706240129074153","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

背景:代谢综合征包括腹部肥胖、胰岛素抵抗、甘油三酯水平升高、高密度脂蛋白降低和高血压等多种病症,对全球健康构成重大挑战。当务之急是确定其在特定人群中的患病率,以制定有效的预防措施:本系统综述和荟萃分析旨在确定代谢综合征在卡塔尔人口中的患病率:方法:采用 PRISMA 指南,以 "代谢综合征 "和 "卡塔尔 "为关键词在 PubMed 上进行了系统检索,检索期至 2023 年 7 月。资格标准包括人类受试者、评估代谢综合征成分的研究、在卡塔尔进行的研究或以卡塔尔受试者为对象的研究。研究质量采用纽卡斯尔-渥太华量表(NOS)进行评估。采用逆方差加权荟萃分析法计算汇总患病率:在 237 项研究中,有 14 项符合我们的纳入标准,合计样本量为 14,772 个卡塔尔人。代谢综合征的总患病率为 26%。ATP III标准和IDF标准在患病率上有显著差异,其中IDF标准的患病率更高。与年轻群体相比,年龄≥40 岁的患病率更高。2018年后的研究报告显示,代谢综合征患病率呈下降趋势:卡塔尔人口的代谢综合征患病率与中东地区的患病率相当。这项研究强调了采取有针对性的干预措施和战略的必要性,尤其是针对老年群体。持续的研究和监测对于跟踪和了解该疾病在卡塔尔的进展情况至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Qatar's Silent Epidemic: A Comprehensive Meta-analysis on the Prevalence of Metabolic Syndrome.

Background: Metabolic syndrome comprises various conditions like abdominal obesity, insulin resistance, elevated triglyceride levels, reduced HDL, and high blood pressure, which pose significant health challenges globally. It's imperative to determine its prevalence in specific populations to formulate effective preventive measures.

Objective: This systematic review and meta-analysis aimed to determine the prevalence of metabolic syndrome in the Qatari population.

Methods: Using the PRISMA guidelines, a systematic search was executed on PubMed until July 2023 with keywords "Metabolic syndrome" and "Qatar." Eligibility criteria included human subjects, studies assessing metabolic syndrome components, and research conducted in Qatar or on Qatari subjects. The quality of the studies was evaluated using the Newcastle-Ottawa Scale (NOS). Pooled prevalence rates were calculated using the inverse variance weighting metaanalysis.

Results: Out of 237 studies, 14 met our inclusion criteria, with a combined sample size of 14,772 from the Qatari population. The overall pooled prevalence of metabolic syndrome was 26%. The ATP III and IDF criteria exhibited significant differences in prevalence rates, with the IDF criteria showing a higher prevalence. Age ≥ 40 years demonstrated a higher prevalence compared to the younger group. Studies post-2018 reported a decreasing trend in metabolic syndrome prevalence.

Conclusion: The prevalence of metabolic syndrome in the Qatari population is comparable to rates in the Middle East. The study underscores the need for tailored interventions and strategies, especially targeting the older age group. Continuous research and monitoring are essential to track and understand the disease's progression in Qatar.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current diabetes reviews
Current diabetes reviews ENDOCRINOLOGY & METABOLISM-
CiteScore
6.30
自引率
0.00%
发文量
158
期刊介绍: Current Diabetes Reviews publishes frontier reviews on all the latest advances on diabetes and its related areas e.g. pharmacology, pathogenesis, complications, epidemiology, clinical care, and therapy. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians who are involved in the field of diabetes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信